Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine and Metformin in PCOS
NCT06836128Phase 3Completed
- Sponsor
- Cairo University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acetylcysteine in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Cairo University. Primary endpoint: Change in Luteinizing Hormone to Follicle-Stimulating Hormone ratio at 3 months. Started Mar 2025; status: completed.
02
Drugs
acetylcysteine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06836128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06836128.